FDA approves new drug, Beyfortus, to protect toddlers and babies against RSV
The monoclonal antibody, called Beyfortus, is the first of its kind likely to be available beyond a small population of immunocompromised children.
Buy Your "EV Range Extender" Now 50% Discount today
Drive Your Electric Vehicle EXTRA MILES, WITHOUT WORRY
